(Alliance News) - Scancell Holdings PLC on Tuesday said it has raised GBP11.9 million in total, from an open offer, placing, and subscription of shares.
Scancell is an Oxford, England-based developer of immunotherapies for treatment of cancer and infectious disease
On Tuesday, it has raised GBP1.2 million through an open offer of 11.1 million shares.
The open offer shares were priced at 11 pence each. Shares in Scancell were up 2.3% to 11.00p each on Tuesday afternoon.
Earlier in December, Scancell said it had raised GBP10.7 million from the placing and subscription of 97.0 million new shares at 11p each. At the time, it announced an open offer, to raise up to a further GBP2.0 million.
"The funds raised today will further drive the company's progress with its lead programmes, including SCIB1, which recently demonstrated an unprecedented objective response rate of 85% in patients with unresectable melanoma in initial data from the Scope study, and Modi-1 through its next clinical steps," said Chief Executive Officer Lindy Durrant at the start of December.
By Sophie Rose, Alliance News senior reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2023 Alliance News Ltd. All Rights Reserved.
Scancell Holdings (SCLP)